Survivin Study: What Is the Next Wave?

Journal of Cellular Physiology

Volumn 197, Issue 1, 2003, Pages 8-29

  Li, Fengzhi ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; PROTEIN KINASE INHIBITOR; SURVIVIN; BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN;

APOPTOSIS; CANCER; CELL DIVISION; CELLULAR DISTRIBUTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; ANIMAL; BIOLOGICAL MODEL; CARDIOVASCULAR DISEASE; CHEMISTRY; IMMUNOTHERAPY; METABOLISM; METHODOLOGY; NEOPLASM; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; CARDIOVASCULAR DISEASES; CELL DIVISION; HUMANS; IMMUNOTHERAPY; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEOPLASMS;

EID: 0141595100     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10327     Document Type: Review

References (187)

1. Adams RR, Carmena M, Earnshaw WC. 2001. Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol 11:49-54.
2. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC. 1998. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351:882-883.
3. Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, et al. 2000a. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96:1921-1925.
4. Adida C, Recher C, Raffoux E, Daniel MT, Taksin AL, Rousselot P, Sigaux F, Degos L, Altieri DC, Dombret H. 2000b. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol 111:196-203.
5. Altieri DC. 2001. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7:542-547.
6. Altieri DC, Marchisio PC, Marchisio C. 1999. Survivin apoptosis: An interloper between cell death and cell proliferation in cancer. Lab Invest 79:1327-1333.
7. Ambrosini G, Adida C, Altieri DC. 1997. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921.
8. Ambrosini G, Adida C, Sirugo G, Altieri DC. 1998. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273:11177-11182.
9. Andersen MH, Pedersen LO, Becker JC, Straten PT. 2001a. Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients. Cancer Res 61:869-872.
10. Andersen MH, Pedersen LO, Capeller B, Brocker EB, Becker JC, thor Straten P. 2001b. Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients. Cancer Res 61:5964-5968.
11. Aoki Y, Feldman GM, Tosato G. 2003. Inhibition of STAT3 signaling induces apoptosis and decreases Survivin expression in primary effusion lymphoma. Blood 101:1535-1542.
12. Azuhata T, Scott D, Takamizawa S, Wen J, Davidoff A, Fukuzawa M, Sandler A. 2001. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma. J Pediatr Surg 36:1785-1791.
13. Banks DP, Plescia J, Altieri DC, Chen J, Rosenberg SH, Zhang H, Ng SC. 2000. Survivin does not inhibit caspase-3 activity. Blood 96:4002-4003.
14. Bao R, Connolly DC, Murphy M, Green J, Weinstein JK, Pisarcik DA, Hamilton TC. 2002. Activation of cancer-specific gene expression by the survivin promoter. J Natl Cancer Inst 94:522-528.
15. Beardsmore DM, Verbeke CS, Davies CL, Guillou PJ, Clark GW. 2003. Apoptotic and proliferative indexes in esophageal cancer. Predictors of response to neoadjuvant therapy apoptosis and proliferation in esophageal cancer. J Gastrointest Surg 7:77-87.
16. Birnbaum MJ, Clem RJ, Miller LK. 1994. An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs. J Virol 68:2521-2528.
17. Blanc-Brude OP, Yu J, Simosa H, Conte MS, Sessa WC, Altieri DC. 2002. Inhibitor of apoptosis protein survivin regulates vascular injury. Nat Med 8:987-994.
18. Bolton MA, Lan W, Powers SE, McCleland ML, Kuang J, Stukenberg PT. 2002. Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation. Mol Biol Cell 13:3064-3077.
19. Boman BM, Fields JZ, Bonham-Carter O, Runquist OA. 2001. Computer modeling implicates stem cell overproduction in colon cancer initiation. Cancer Res 61:8408-8411.
20. Carter BZ, Milella M, Altieri DC, Andreeff M. 2001. Cytokine-regulated expression of survivin in myeloid leukemia. Blood 97:2784-2790.
21. Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS. 2002. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20:1063-1068.
22. Chantalat L, Skoufias DA, Kleman JP, Jung B, Dideberg O, Margolis RL. 2000. Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions. Mol Cell 6:183-189.
23. Chen Z, Naito M, Hori S, Mashima T, Yamori T, Tsuruo T. 1999. A human IAP-family gene, apollon, expressed in human brain cancer cells. Biochem Biophys Res Commun 264:847-854.
24. Chen J, Wu W, Tahir SK, Kroeger PE, Rosenberg SH, Cowsert LM, Bennett F, Krajewski S, Krajewska M, Welsh K, et al. 2000. Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis, and anchorage-independent growth. Neoplasia 2:235-241.
25. Chen J, Jin S, Tahir SK, Zhang H, Liu X, Sarthy AV, McGonigal TP, Liu Z, Rosenberg SH, Ng SC. 2003. Survivin enhances Aurora-B kinase activity and localizes Aurora-B in human cells. J Biol Chem 278:486-490.
26. Chen Y, Kramer DL, Li F, Porter CW. 2003. Rapid loss of inhibitor of apoptosis proteins precedes polyamine analogue-induced apotosis in human melanoma cells. Oncogene, in press.
27. Chiodino C, Cesinaro AM, Ottani D, Fantini F, Giannetti A, Trentini GP, Pincelli C. 1999. Communication: Expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol 113:415-418.
28. Choi KS, Lee TH, Jung MH. 2003. Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells. Cancer Gene Ther 10:87-95.
29. Choy JC, Granville DJ, Hunt DW, McManus BM. 2001. Endothelial cell apoptosis: Biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 33:1673-1690.
30. Clark SJ, Melki J. 2002. DNA methylation and gene silencing in cancer: Which is the guilty party? Oncogene 21:5380-5387.
31. Conway EM, Pollefeyt S, Cornelissen J, DeBaere I, Steiner-Mosonyi M, Ong K, Baens M, Collen D, Schuh AC. 2000. Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions. Blood 95:1435-1442.
32. Cooke CA, Heck MM, Earnshaw WC. 1987. The inner centromere protein (INCENP) antigens: Movement from inner centromere to midbody during mitosis. J Cell Biol 105:2053-2067.
33. Crook NE, Clem RJ, Miller LK. 1993. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol 67:2168-2174.
34. Das A, Tan WL, Teo J, Smith DR. 2002. Expression of survivin in primary glioblastomas. J Cancer Res Clin Oncol 128:302-306.
35. Decker T, Hipp S, Ringshausen I, Bogner C, Oelsner M, Schneller F, Peschel C. 2003. Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin. Blood 101:278-285.
36. Deveraux QL, Reed JC. 1999. IAP family proteins - suppressors of apoptosis. Genes Dev 13:239-252.
37. Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M. 2002. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res 22:2377-2383.
38. Du C, Fang M, Li Y, Li L, Wang X. 2000. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33-42.
39. Duckett CS, Nava VE, Gedrich RW, Clem RJ, Van Dongen JL, Gilfillan MC, Shiels H, Hardwick JM, Thompson CB. 1996. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. Embo J 15:2685-2694.
40. Earnshaw WC, Cooke CA. 1991. Analysis of the distribution of the INCENPs throughout mitosis reveals the existence of a pathway of structural changes in the chromosomes during metaphase and early events in cleavage furrow formation. J Cell Sci 98(Pt 4): 443-461.
41. Eckley DM, Ainsztein AM, Mackay AM, Goldberg IG, Earnshaw WC. 1997. Chromosomal proteins and cytokinesis: Patterns of cleavage furrow formation and inner centromere protein positioning in mitotic heterokaryons and mid-anaphase cells. J Cell Biol 136:1169-1183.
42. Ehrlich M. 2002. DNA methylation in cancer: Too much, but also too little. Oncogene 21:5400-5413.
43. Formby B, Wiley TS. 1999. Bcl-2, survivin, and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: Inhibition of cell growth and induction of apoptosis. Mol Cell Biochem 202:53-61.
44. Fortugno P, Wall NR, Giodini A, O'Connor DS, Plescia J, Padgett KM, Tognin S, Marchisio PC, Altieri DC. 2002. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci 115:575-585.
45. Fraser AG, James C, Evan GI, Hengartner MO. 1999. Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr Biol 9:292-301.
46. Fukuda S, Pelus LM. 2002. Elevation of survivin levels by hematopoietic growth factors occurs in quiescent CD34(+) hematopoietic stem and progenitor cells before cell cycle entry. Cell Cycle 1:322-326.
47. Gazzaniga P, Gradilone A, Giuliani L, Gandini O, Silvestri I, Nofroni I, Saccani G, Frati L, Agliano AM. 2003. Expression and prognostic significance of LIVIN, SURVIVIN, and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 14:85-90.
48. Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R, Shroyer KR. 2001. Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol 32:119-125.
49. Giodini A, Kallio MJ, Wall NR, Gorbsky GJ, Tognin S, Marchisio PC, Symons M, Altieri DC. 2002. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res 62:2462-2467.
50. Grabowski P, Kuhnel T, Muhr-Wilkenshoff F, Heine B, Stein H, Hopfner M, Germer CT, Scherubl H. 2003. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 88:115-119.
51. Gradilone A, Gazzaniga P, Ribuffo D, Scarpa S, Cigna E, Vasaturo F, Bottoni U, Innocenzi D, Calvieri S, Scuderi N, et al. 2003. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients. J Clin Oncol 21:306-312.
52. Griffith TS, Fialkov JM, Scott DL, Azuhata T, Williams RD, Wall NR, Altieri DC, Sandler AD. 2002. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Cancer Res 62:3093-3099.
53. Grossman D, McNiff JM, Li F, Altieri DC. 1999a. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 113:1076-1081.
54. Grossman D, McNiff JM, Li F, Altieri DC. 1999b. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 79:1121-1126.
55. Grossman D, Kim PJ, Blanc-Brude OP, Brash DE, Tognin S, Marchisio PC, Altieri DC. 2001a. Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J Clin Invest 108:991-999.
56. Grossman D, Kim PJ, Schechner JS, Altieri DC. 2001b. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci USA 98:635-640.
57. Guevara NV, Chen KH, Chan L. 2001. Apoptosis in atherosclerosis: Pathological and pharmacological implications. Pharmacol Res 44:59-71.
58. Harfouche R, Hassessian HM, Guo Y, Faivre V, Srikant CB, Yancopoulos GD, Hussain SN. 2002. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc Res 64:135-147.
59. Hattori M, Sakamoto H, Satoh K, Yamamoto T. 2001. DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes. Cancer Lett 169:155-164.
60. Hirohashi Y, Torigoe T, Maeda A, Nabeta Y, Kamiguchi K, Sato T, Yoda J, Ikeda H, Hirata K, Yamanaka N, Sato N. 2002. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Clin Cancer Res 8:1731-1739.
61. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. 2002. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277:3247-3257.
62. Ikeguchi M, Kaibara N. 2002. Survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma. Br J Cancer 87:883-887.
63. Ikeguchi M, Hirooka Y, Kaibara N. 2002a. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Cancer 95:1938-1945.
64. Ikeguchi M, Liu J, Kaibara N. 2002b. Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45 during cisplatin treatment. Apoptosis 7:23-29.
65. Ikeguchi M, Ueda T, Sakatani T, Hirooka Y, Kaibara N. 2002c. Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn Mol Pathol 11:33-40.
66. Ikeguchi M, Ueta T, Yamane Y, Hirooka Y, Kaibara N. 2002d. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. Clin Cancer Res 8:3131-3136.
67. Ikehara M, Oshita F, Kameda Y, Ito H, Ohgane N, Suzuki R, Saito H, Yamada K, Noda K, Mitsuda A. 2002. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung. Oncol Rep 9:835-838.
68. Islam A, Kageyama H, Hashizume K, Kaneko Y, Nakagawara A. 2000a. Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, survivin-beta/2B. Med Pediatr Oncol 35:550-553.
69. Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y, Nakagawara A. 2000b. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19:617-623.
70. Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M, Takase K, Moriyama M, Kawano H, Hayashida M, et al. 2000. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31:1080-1085.
71. Izawa A, Kobayashi D, Nasu S, Saito K, Moriai R, Asanuma K, Nakamura M, Yagihashi A, Watanabe N. 2002. Relevance of c-erbB2, PLU-1, and survivin mRNA expression to diagnostic assessment of breast cancer. Anticancer Res 22:2965-2969.
72. Jiang X, Wilford C, Duensing S, Munger K, Jones G, Jones D. 2001. Participation of Survivin in mitotic and apoptotic activities of normal and tumor-derived cells. J Cell Biochem 83:342-354.
73. Joazeiro CA, Weissman AM. 2000. RING finger proteins: Mediators of ubiquitin ligase activity. Cell 102:549-552.
74. Jones G, Jones D, Zhou L, Steller H, Chu Y. 2000. Deterin, a new inhibitor of apoptosis from Drosophila melanogaster. J Biol Chem 275:22157-22165.
75. Kajiwara Y, Yamasaki F, Hama S, Yahara K, Yoshioka H, Sugiyama K, Arita K, Kurisu K. 2003. Expression of survivin in astrocytic tumors. Cancer 97:1077-1083.
76. Kallio MJ, Nieminen M, Eriksson JE. 2001. Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation and mitotic exit. Faseb J 15:2721-2723.
77. Kallio MJ, McCleland ML, Stukenberg PT, Gorbsky GJ. 2002. Inhibition of aurora B kinase blocks chromosome segregation, overrides the spindle checkpoint, and perturbs microtubule dynamics in mitosis. Curr Biol 12:900-905.
78. Kanwar JR, Shen WP, Kanwar RK, Berg RW, Krissansen GW. 2001. Effects of survivin antagonists on growth of established tumors and b7-1 immunogene therapy. J Natl Cancer Inst 93:1541-1552.
79. Kappler M, Kohler T, Kampf C, Diestelkotter P, Wurl P, Schmitz M, Bartel F, Lautenschlager C, Rieber EP, Schmidt H, et al. 2001. Increased survivin transcript levels: An independent negative predictor of survival in soft tissue sarcoma patients. Int J Cancer 95:360-363.
80. Kasof GM, Gomes BC. 2001. Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 276:3238-3246.
81. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J, Fujii Y. 2001. Expression of survivin in esophageal cancer: Correlation with the prognosis and response to chemotherapy. Int J Cancer 95:92-95.
82. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. 1998. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071-5074.
83. Kawasaki H, Toyoda M, Shinohara H, Okuda J, Watanabe I, Yamamoto T, Tanaka K, Tenjo T, Tanigawa N. 2001. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91:2026-2032.
84. Kessler JH, Beekman NJ, Bres-Vloemans SA, Verdijk P, van Veelen PA, Kloosterman-Joosten AM, Vissers DC, ten Bosch GJ, Kester MG, Sijts A, et al. 2001. Efficient identification of novel HLA-A(*)0201)-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. J Exp Med 193:73-88.
85. Kim HS, Shiraki K, Park SH. 2002. Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res 22:805-808.
86. Kobayashi K, Hatano M, Otaki M, Ogasawara T, Tokuhisa T. 1999. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc Natl Acad Sci USA 96:1457-1462.
87. Krieg A, Mahotka C, Krieg T, Grabsch H, Muller W, Takeno S, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD. 2002. Expression of different survivin variants in gastric carcinomas: First clues to a role of survivin-2B in tumor progression. Br J Cancer 86:737-743.
88. Kuttler F, Valnet-Rabier MB, Angonin R, Ferrand C, Deconinck E, Mougin C, Cahn JY, Fest T. 2002. Relationship between expression of genes involved in cell cycle control and apoptosis in diffuse large B cell lymphoma: A preferential survivin-cyclin B link. Leukemia 16:726-735.
89. Lehner R, Lucia MS, Jarboe EA, Orlicky D, Shroyer AL, McGregor JA, Shroyer KR. 2002. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Appl Immunohistochem Mol Morphol 10:134-138.
90. Leverson JD, Huang HK, Forsburg SL, Hunter T. 2002. The Schizosaccharomyces pombe aurora-related kinase Ark1 interacts with the inner centromere protein Pic1 and mediates chromosome segregation and cytokinesis. Mol Biol Cell 13:1132-1143.
91. Li F, Altieri DC. 1999a. The cancer antiapoptosis mouse survivin gene: Characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res 59:3143-3151.
92. Li F, Altieri DC. 1999b. Transcriptional analysis of human survivin gene expression. Biochem J 344(Pt 2):305-311.
93. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC. 1998. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580-584.
94. Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, Villa A, Marchisio PC, Altieri DC. 1999. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol 1:461-466.
95. Li F, Flanary PL, Altieri DC, Dohlman HG. 2000. Cell division regulation by BIR1, a member of the inhibitor of apoptosis family in yeast. J Biol Chem 275:6707-6711.
96. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, Korneluk RG. 1996. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379:349-353.
97. Lo Muzio L, Staibano S, Pannone G, Mignogna MD, Mariggio A, Salvatore G, Chieffi P, Tramontano D, De Rosa G, Altieri DC. 2001. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 70:249-254.
98. Lu CD, Altieri DC, Tanigawa N. 1998. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58:1808-1812.
99. Mahboubi K, Li F, Plescia J, Kirkiles-Smith NC, Mesri M, Du Y, Carroll JM, Elias JA, Altieri DC, Pober JS. 2001. Interleukin-11 upregulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway. Lab Invest 81:327-334.
100. Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD. 1999. Survivin-deltaEx3 and survivin-2B: Two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 59:6097-6102.
101. Mahotka C, Krieg T, Krieg A, Wenzel M, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD. 2002a. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int J Cancer 100:30-36.
102. Mahotka C, Liebmann J, Wenzel M, Suschek CV, Schmitt M, Gabbert HE, Gerharz CD. 2002b. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ 9:1334-1342.
103. McManus MT, Sharp PA. 2002. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 3:737-747.
104. Mesri M, Morales-Ruiz M, Ackermann EJ, Bennett CF, Pober JS, Sessa WC, Altieri DC. 2001a. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol 158:1757-1765.
105. Mesri M, Wall NR, Li J, Kim RW, Altieri DC. 2001b. Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest 108:981-990.
106. Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, Wen SF, Wang L, Kirschmeier P, Bishop WR, et al. 2002. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21:2613-2622.
107. Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, Martin C, Font A, Barnadas A, Abad A. 1999. A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 17:2100-2104.
108. Mori A, Wada H, Nishimura Y, Okamoto T, Takemoto Y, Kakishita E. 2002. Expression of the antiapoptosis gene survivin in human leukemia. Int J Hematol 75:161-165.
109. Muchmore SW, Chen J, Jakob C, Zakula D, Matayoshi ED, Wu W, Zhang H, Li F, Ng SC, Altieri DC. 2000. Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin. Mol Cell 6:173-182.
110. Murata-Hori M, Wang YL. 2002a. Both midzone and astral microtubules are involved in the delivery of cytokinesis signals: Insights from the mobility of aurora B. J Cell Biol 159:45-53.
111. Murata-Hori M, Wang YL. 2002b. The kinase activity of aurora B is required for kinetochore-microtubule interactions during mitosis. Curr Biol 12:894-899.
112. Nasu S, Yagihashi A, Izawa A, Saito K, Asanuma K, Nakamura M, Kobayashi D, Okazaki M, Watanabe N. 2002. Survivin mRNA expression in patients with breast cancer. Anticancer Res 22:1839-1843.
113. Notarbartolo M, Cervello M, Dusonchet L, Cusimano A, D'Alessandro N. 2002. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas, and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins). Cancer Lett 180:91-101.
114. O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, Tognin S, Marchisio PC, Altieri DC. 2000a. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA 97:13103-13107.
115. O'Connor DS, Schechner JS, Adida C, Mesri M, Rothermel AL, Li F, Nath AK, Pober JS, Altieri DC. 2000b. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol 156:393-398.
116. O'Connor DS, Wall NR, Porter AC, Altieri DC. 2002. A p34(cdc2) survival checkpoint in cancer. Cancer Cell 2:43-54.
117. Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M, Takano Y. 2001. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163:109-116.
118. Olie RA, Simoes-Wust AP, Baumann B, Leech SH, Fabbro D, Stahel RA, Zangemeister-Wittke U. 2000. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 60:2805-2809.
119. Otaki M, Hatano M, Kobayashi K, Ogasawara T, Kuriyama T, Tokuhisa T. 2000. Cell cycle-dependent regulation of TIAP/m-survivin expression. Biochim Biophys Acta 1493:188-194.
120. Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, Li F, Altieri DC, Sessa WC. 2000. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 275:9102-9105.
121. Pennati M, Colella G, Folini M, Citti L, Daidone MG, Zaffaroni N. 2002. Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis. J Clin Invest 109:285-286.
122. Poetker DM, Sandler AD, Scott DL, Smith RJ, Bauman NM. 2002. Survivin expression in juvenile-onset recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 111:957-961.
123. Reed JC, Bischoff JR. 2000. BIRinging chromosomes through cell division - and survivin' the experience. Cell 102:545-548.
124. Richter BW, Mir SS, Eiben LJ, Lewis J, Reffey SB, Frattini A, Tian L, Frank S, Youle RJ, Nelson DL, et al. 2001. Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family. Mol Cell Biol 21:4292-4301.
125. Rodel F, Hoffmann J, Grabenbauer GG, Papadopoulos T, Weiss C, Gunther K, Schick C, Sauer R, Rodel C. 2002. High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection. Strahlenther Onkol 178:426-435.
126. Rodriguez JA, Span SW, Ferreira CG, Kruyt FA, Giaccone G. 2002. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin. Exp Cell Res 275:44-53.
127. Rohayem J, Diestelkoetter P, Weigle B, Oehmichen A, Schmitz M, Mehlhorn J, Conrad K, Rieber EP. 2000. Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. Cancer Res 60:1815-1817.
128. Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, Ginsburg GS. 2001. Atherosclerosis and cancer: Common molecular pathways of disease development and progression. Ann NY Acad Sci 947:271-292; discussion 292-273.
129. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV. 1995. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243-1252.
130. Ruberg FL, Leopold JA, Loscalzo J. 2002. Atherothrombosis: Plaque instability and thrombogenesis. Prog Cardiovasc Dis 44:381-394.
131. Saitoh Y, Yaginuma Y, Ishikawa M. 1999. Analysis of Bcl-2, Bax, and Survivin genes in uterine cancer. Int J Oncol 15:137-141.
132. Salvesen GS, Duckett CS. 2002. IAP proteins: Blocking the road to death's door. Nat Rev Mol Cell Biol 3:401-410.
133. Sandler A, Scott D, Azuhata T, Takamizawa S, O'Dorisio S. 2002. The survivin:Fas ratio is predictive of recurrent disease in neuroblastoma. J Pediatr Surg 37:507-511.
134. Sarela AI, Macadam RC, Farmery SM, Markham AF, Guillou PJ. 2000. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46:645-650.
135. Sarela AI, Scott N, Ramsdale J, Markham AF, Guillou PJ. 2001. Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol 8:305-310.
136. Sarela AI, Verbeke CS, Ramsdale J, Davies CL, Markham AF, Guillou PJ. 2002. Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. Br J Cancer 86:886-892.
137. Sasaki T, Lopes MB, Hankins GR, Helm GA. 2002. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system. Acta Neuropathol (Berl) 104:105-109.
138. Satoh K, Kaneko K, Hirota M, Masamune A, Satoh A, Shimosegawa T. 2001. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 92:271-278.
139. Schmitz M, Diestelkoetter P, Weigle B, Schmachtenberg F, Stevanovic S, Ockert D, Rammensee HG, Rieber EP. 2000. Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides. Cancer Res 60:4845-4849.
140. Shankar SL, Mani S, O'Guin KN, Kandimalla ER, Agrawal S, Shafit-Zagardo B. 2001. Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways. J Neurochem 79:426-436.
141. Sharief MK, Semra YK. 2002. Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis. Arch Neurol 59:1115-1121.
142. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK, Oh BH. 2001. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40:1117-1123.
143. Skoufias DA, Mollinari C, Lacroix FB, Margolis RL. 2000. Human survivin is a kinetochore-associated passenger protein. J Cell Biol 151:1575-1582.
144. Smith SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM, Altieri DC. 2001. Urine detection of survivin and diagnosis of bladder cancer. Jama 285:324-328.
145. Speliotes EK, Uren A, Vaux D, Horvitz HR. 2000. The survivin-like C. elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone. Mol Cell 6:211-223.
146. Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tokuda M. 2002. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors. Int J Oncol 21:315-320.
147. Suzuki A, Hayashida M, Ito T, Kawano H, Nakano T, Miura M, Akahane K, Shiraki K. 2000a. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene 19:3225-3234.
148. Suzuki A, Ito T, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Akahane K, Nakano T, Miura M, Shiraki K. 2000b. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 19:1346-1353.
149. Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC. 1999. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341:452-453.
150. Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. 2002a. Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma. Int J Mol Med 10:211-216.
151. Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. 2002b. expression correlates with clinical stage, histological grade, invasive behavior, and survival rate in endometrial carcinoma. Cancer Lett 184:105-116.
152. Takamizawa S, Scott D, Wen J, Grundy P, Bishop W, Kimura K, Sandler A. 2001. The survivin:fas ratio in pediatric renal tumors. J Pediatr Surg 36:37-42.
153. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC. 1998. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315-5320.
154. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. 2000. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6:127-134.
155. Temme A, Rieger M, Reber F, Lindemann D, Weigle B, Diestelkoetter-Bachert P, Ehninger G, Tatsuka M, Terada Y, Rieber EP. 2003. Localization, dynamics, and function of survivin revealed by expression of functional SurvivinDsRed fusion proteins in the living cell. Mol Biol Cell 14:78-92.
156. Tran J, Rak J, Sheehan C, Saibil SD, LaCasse E, Korneluk RG, Kerbel RS. 1999. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun 264:781-788.
157. Tran J, Master Z, Yu JL, Rak J, Dumont DJ, Kerbel RS. 2002. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci USA 99:4349-4354.
158. Uren AG, Beilharz T, O'Connell MJ, Bugg SJ, van Driel R, Vaux DL, Lithgow T. 1999. Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division. Proc Natl Acad Sci USA 96:10170-10175.
159. Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL, Choo KH. 2000. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol 10:1319-1328.
160. Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C, Lal A, Wang CJ, Beaudry GA, Ciriello KM, et al. 1999. Analysis of human transcriptomes. Nat Genet 23:387-388.
161. Verdecia MA, Huang H, Dutil E, Kaiser DA, Hunter T, Noel JP. 2000. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat Struct Biol 7:602-608.
162. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, Vaux DL. 2000. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102:43-53.
163. Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM. 2000. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 10:1359-1366.
164. Vucic D, Deshayes K, Ackerly H, Pisabarro MT, Kadkhodayan S, Fairbrother WJ, Dixit VM. 2002. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP). J Biol Chem 277:12275-12279.
165. Wakana Y, Kasuya K, Katayanagi S, Tsuchida A, Aoki T, Koyanagi Y, Ishii H, Ebihara Y. 2002. Effect of survivin on cell proliferation and apoptosis in gastric cancer. Oncol Rep 9:1213-1218.
166. Wall NR, O'Connor DS, Plescia J, Pommier Y, Altieri DC. 2003. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. Cancer Res 63:230-235.
167. Wang HW, Sharp TV, Koumi A, Koentges G, Boshoff C. 2002. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. Embo J 21:2602-2615.
168. Ward NL, Dumont DJ. 2002. The angiopoietins and Tie2/Tek: Adding to the complexity of cardiovascular development. Semin Cell Dev Biol 13:19-27.
169. Wheatley SP, Carvalho A, Vagnarelli P, Earnshaw WC. 2001. INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis. Curr Biol 11:886-890.
170. Wittmann S, Bali P, Donapaty S, Nimmanapalli R, Guo F, Yamaguchi H, Huang M, Jove R, Wang HG, Bhalla K. 2003. Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis. Cancer Res 63:93-99.
171. Wright ME, Han DK, Hockenbery DM. 2000. Caspase-3 and inhibitor of apoptosis protein(s) interactions in Saccharomyces cerevisiae and mammalian cells. FEBS Lett 481:13-18.
172. Wurl P, Kappler M, Meye A, Bartel F, Kohler T, Lautenschlager C, Bache M, Schmidt H, Taubert H. 2002. Co-expression of survivin and TERT and risk of tumor-related death in patients with soft-tissue sarcoma. Lancet 359:943-945.
173. Xia C, Xu Z, Yuan X, Uematsu K, You L, Li K, Li L, McCormick F, Jablons DM. 2002. Induction of apoptosis in mesothelioma cells by anti-survivin oligonucleotides. Mol Cancer Ther 1:687-694.
174. Xing N, Qian J, Bostwick D, Bergstralh E, Young CY. 2001. Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin. Prostate 48:7-15.
175. Yagihashi A, Asanuma K, Nakamura M, Araya J, Mano Y, Torigoe T, Kobayashi D, Watanabe N. 2001. Detection of anti-survivin antibody in gastrointestinal cancer patients. Clin Chem 47:1729-1731.
176. Yamamoto T, Manome Y, Nakamura M, Tanigawa N. 2002. Down-regulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer. Eur J Cancer 38:2316-2324.
177. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407:242-248.
178. Yoon HJ, Carbon J. 1999. Participation of Bir1p, a member of the inhibitor of apoptosis family, in yeast chromosome segregation events. Proc Natl Acad Sci USA 96:13208-13213.
179. Yoshida H, Ishiko O, Sumi T, Matsumoto Y, Ogita S. 2001. Survivin, bcl-2, and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas. Int J Oncol 19:537-542.
180. Yu J, Leung WK, Ebert MP, Ng EK, Go MY, Wang HB, Chung SC, Malfertheiner P, Sung JJ. 2002. Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer 87:91-97.
181. Zaffaroni N, Pennati M, Colella G, Perego P, Supino R, Gatti L, Pilotti S, Zunino F, Daidone MG. 2002. Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer. Cell Mol Life Sci 59:1406-1412.
182. Zamore PD. 2001. RNA interference: Listening to the sound of silence. Nat Struct Biol 8:746-750.
183. Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ, Boman BM. 2001. Evidence that APC regulates survivin expression: A possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61:8664-8667.
184. Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR. 2000. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci 113(Pt 23):4363-4371.
185. Zhou M, Gu L, Li F, Zhu Y, Woods WG, Findley HW. 2002. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. J Pharmacol Exp Ther 303:124-131.
186. Zhu L, Fukuda S, Cordis G, Das DK, Maulik N. 2001. Anti-apoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett 508:369-374.
187. Zhu Y, Roshal M, Li F, Blackett J, Planelles V. 2003. Upregulation of survivin by HIV-1 Vpr. Apoptosis 8:71-79.